The dissection model of the heart
- Known as:
- The dissection model heart
- Catalog number:
- KMA0882E
- Product Quantity:
- Set
- Category:
- -
- Supplier:
- Kemaj
- Gene target:
- The dissection model the heart
Ask about this productRelated genes to: The dissection model of the heart
- Gene:
- MHRT NIH gene
- Name:
- myosin heavy chain associated RNA transcript
- Previous symbol:
- -
- Synonyms:
- Myheart
- Chromosome:
- 14q11.2
- Locus Type:
- RNA, long non-coding
- Date approved:
- 2014-09-17
- Date modifiied:
- 2017-07-24
Related products to: The dissection model of the heart
*Brain Heart CC Agar USE For selective isolation and cultivation of pathogenic fastidious fungi from specimens heavily contaminated with bacteria.1.5-times expansion model of ear dissection, external, middle & internal ear, 4 parts1.5-times expansion model of ear dissection, external, middle & internal ear, 4 parts, 120x60x901.5-times transparent ear model with assistive listening devises1.5-times transparent ear model with assistive listening devises, 1.5 times2 times natural size study model2 times natural size study model, Natural size26 cm model of human body showing chinese acupuncture points26 cm model of human body showing chinese acupuncture points, 110X55x2703 time expansion model of the eyeball, 6 parts, plastic pvc3 time expansion model of the eyeball, 6 parts, plastic pvc, 130x100x1003 times Dental corona model, 15 parts3 times Dental corona model, 15 parts, Natural size3-times expansion model of ear dissection, external middle and internal ear, 4 parts3-times expansion model of ear dissection, external middle and internal ear, 4 parts, 360x150x220 Related articles to: The dissection model of the heart
- Moderately hypofractionated radiotherapy (MHRT) may shorten treatment duration for cervical cancer but raises concerns regarding toxicity due to substantial interfractional pelvic organ motion. This prospective study evaluated the feasibility, workflow efficiency, dosimetric benefits, and acute toxicities of daily online adaptive radiotherapy (oART)-guided MHRT. - Source: PubMed
Publication date: 2026/08/04
Zeng ZhengChen YiningMeng XiangyinSun YuliangYan JunfangHu KeZhang Fuquan - - Source: PubMed
Publication date: 2026/07/20
Eid TouficAl-Bitar TarekMohamad Osama - Prostate cancer is the most frequently diagnosed male malignancy in Colombia. While modern radiotherapy techniques allow for hypofractionated schedules due to the low alpha/beta ratio of prostate adenocarcinoma, real-world comparative data between moderate and ultra-hypofractionation in Latin American settings remain limited. - Source: PubMed
Publication date: 2026/05/22
Cifuentes-Quin JavierGarcia-Montañez Yiselle THurtado-Ortiz AlexandraCruz JhonatanLagares Luis CarlosOlarte-Licht Luis ALicht-Ardila MaricelManrique-Hernández Edgar Fabián - This study aimed to identify dosimetric and clinical risk factors for ≥Grade 2 radiation pneumonitis (RP) in patients with primary lung cancer undergoing moderately hypofractionated radiotherapy (MHRT). - Source: PubMed
Publication date: 2026/05/09
Yang YuanYouLuo FengXiaWang ChaoRen Gang - Moderately hypofractionated radiation therapy (MHRT) offers practical advantages for postoperative prostate cancer (PC) patients. However, concerns persist regarding long-term genitourinary (GU) toxicity. This prospective cohort study aims to evaluate late toxicities, disease control outcomes, and to identify predictors of late GU toxicity following MHRT. - Source: PubMed
Publication date: 2026/03/21
Ren Xue-YingQin Shang-BinLiu ChaoQi XinBai YunChen Jia-YanLyu FengGao YanLi Xiao-YingLi Hong-ZhenGao Xian-ShuMa Ming-Wei